LCAT (P04180) variants and mutations
LCAT (also known as P04180) is a human protein-coding gene encoding a phosphatidylcholine-sterol acyltransferase protein. It esterifies free cholesterol on circulating lipoproteins, allowing HDL particles to mature and participate in reverse cholesterol transport. Biallelic loss-of-function variants cause familial LCAT deficiency or fish-eye disease, with very low HDL and variable corneal, renal, and hematologic manifestations. This analysis covers 667 LCAT variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes LCAT deficiency, Fish-eye disease, and Norum disease. Example LCAT variants include G2V, P3L, and P3Q.
Variant analysis overview
- Gene: LCAT
- Protein: P04180
- UniProt accession: P04180
- Organism: Homo sapiens
- Variants analyzed: 667
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 461 unspecified-consequence records; 1 natural variant; 104 missense variants; 18 frameshift variants; 3 stop-gained variants; 68 synonymous variants; 3 in-frame insertions; 9 in-frame deletions; 2 stop lost; 1 substitution
- Prediction scores: 533 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: LCAT deficiency, Fish-eye disease, Norum disease, fish eye disease, Familial LCAT deficiency, Abnormality of the cardiovascular system, small intestine neoplasm, metabolic syndrome, hepatocellular carcinoma, chronic kidney disease, familial idiopathic steroid-resistant nephrotic syndrome, Hyperlipoproteinemia type 5.
Protein structure and variant hotspots
- Protein features: 6 post-translational modification sites.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable LCAT variants
Examples include G2V, P3L, P3Q, P3R, P4S, G5S, S6F, P7R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2V (p.Gly2Val), Ensembl rs2058314435, REVEL 0.41, CADD 23.70
- P3L (p.Pro3Leu), rs753021814, ClinGen CA8121182, ClinVar RCV002376346, ClinVar RCV003103552, REVEL 0.31, CADD 0.01, Conflicting interpretations, not provided; Cardiovascular phenotype
- P3Q (p.Pro3Gln), ExAC rs753021814, TOPMed rs753021814, gnomAD rs753021814, REVEL 0.24, CADD 0.02, Likely benign
- P3R (p.Pro3Arg), ExAC rs753021814, TOPMed rs753021814, gnomAD rs753021814, Likely benign
- P4S (p.Pro4Ser), rs1323619408, ClinGen CA396383085, ClinVar RCV004291589, TOPMed rs1323619408, REVEL 0.26, CADD 8.15, Uncertain significance, Cardiovascular phenotype
- G5S (p.Gly5Ser), rs1394758775, ClinGen CA396383075, ClinVar RCV002676247, ClinVar RCV004066859, REVEL 0.26, CADD 14.30, Uncertain significance, Cardiovascular phenotype; Fish-eye disease; Norum disease
- S6F (p.Ser6Phe), NCI-TCGA Cosmic COSV9986, REVEL 0.28, CADD 22.50, Variant assessed as somatic; moderate impact.
- P7R (p.Pro7Arg), Ensembl rs2058314154, REVEL 0.39, CADD 18.10
- P7S (p.Pro7Ser), NCI-TCGA Cosmic COSV9986, Variant assessed as somatic; moderate impact.
- W8* (p.Trp8Ter), rs2544411002, ClinGen CA396383039, ClinVar RCV002717215, CADD 34.00, Pathogenic
- Q9P (p.Gln9Pro), TOPMed rs1297313253, gnomAD rs1297313253, REVEL 0.53, CADD 15.80, Uncertain significance, Cardiovascular phenotype
- V11M (p.Val11Met), Ensembl rs1598205941
- T12M (p.Thr12Met), rs560140762, ClinGen CA8121180, ClinVar RCV002033242, ClinVar RCV002468342, REVEL 0.27, CADD 13.20, Uncertain significance, Fish-eye disease; Norum disease; not provided
- T12P (p.Thr12Pro), NCI-TCGA Cosmic COSV9986, Variant assessed as somatic; moderate impact.
- L13P (p.Leu13Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P21T (p.Pro21Thr), Ensembl rs2058313732, REVEL 0.34, CADD 12.30
- A22V (p.Ala22Val), gnomAD rs1192138987, CADD 8.74
- A23T (p.Ala23Thr), rs544182517, ClinGen CA283164386, ClinVar RCV002369481, TOPMed rs544182517, REVEL 0.30, CADD 0.84, Likely benign, Cardiovascular phenotype
- A23V (p.Ala23Val), TOPMed rs1195448644, gnomAD rs1195448644, REVEL 0.22, CADD 23.50
- P24L (p.Pro24Leu), Ensembl rs1051642208, REVEL 0.36, CADD 22.30
- P24R (p.Pro24Arg), Ensembl rs1051642208, REVEL 0.52, CADD 21.60
- W26* (p.Trp26Ter), NCI-TCGA TCGA novel, CADD 35.00, Variant assessed as somatic; high impact.
- W26C (p.Trp26Cys), Ensembl rs2151322118, REVEL 0.82, CADD 27.10
- N29I (p.Asn29Ile), UniProt VAR 039020, REVEL 0.82, CADD 26.10, Pathogenic, in LCATD
- N29S (p.Asn29Ser), TOPMed rs1253171555, gnomAD rs1253171555, REVEL 0.60, CADD 24.60
- V30G (p.Val30Gly), ExAC rs750103024, gnomAD rs750103024, REVEL 0.78, CADD 26.20
- L31F (p.Leu31Phe), TOPMed rs2058313346, REVEL 0.50, CADD 23.50
- L31R (p.Leu31Arg), TOPMed rs1403044426, gnomAD rs1403044426, REVEL 0.79, CADD 26.30
- L31V (p.Leu31Val), TOPMed rs2058313346
- F32I (p.Phe32Ile), NCI-TCGA Cosmic COSV5045, Variant assessed as somatic; moderate impact.
- P34L (p.Pro34Leu), rs121908051, ClinGen CA116419, ClinVar RCV000003847, ClinVar RCV002504740, REVEL 0.77, CADD 23.10, Pathogenic, Fish-eye disease; Norum disease; not provided
- P34Q (p.Pro34Gln), rs121908051, UniProt VAR 039021, gnomAD rs121908051, REVEL 0.81, CADD 26.20, Pathogenic, in FED
- P34R (p.Pro34Arg), gnomAD rs121908051, REVEL 0.83, CADD 26.30, Pathogenic, in FED
- H35L (p.His35Leu), Ensembl rs2151322089
- H35N (p.His35Asn), Ensembl rs1349470729
- T36I (p.Thr36Ile), rs1371480236, ClinGen CA396382684, ClinVar RCV002626912, ClinVar RCV005019298, REVEL 0.39, CADD 22.30, Uncertain significance, not provided; Norum disease; Fish-eye disease
- T37K (p.Thr37Lys), TOPMed rs971887742, gnomAD rs971887742, REVEL 0.54, CADD 21.40, Pathogenic, in LCATD
- T37M (p.Thr37Met), rs971887742, ClinGen CA283164291, ClinVar RCV001946938, ClinVar RCV002458885, REVEL 0.71, CADD 25.10, Conflicting interpretations, Fish-eye disease; Norum disease; Cardiovascular phenotype
- K39* (p.Lys39Ter), gnomAD rs1389355640, CADD 36.00, Likely pathogenic
- K39E (p.Lys39Glu), gnomAD rs1389355640, REVEL 0.28, CADD 21.70, Likely pathogenic
- K39M (p.Lys39Met), Ensembl rs2058312868, REVEL 0.45, AlphaMissense 0.26, Uncertain significance, Norum disease; Fish-eye disease
- K39R (p.Lys39Arg), rs2058312868, ClinGen CA396382632, ClinVar RCV002329867, AlphaMissense 0.26, MetaLR 0.87, Uncertain significance, Cardiovascular phenotype
- A40P (p.Ala40Pro), rs2544410688, ClinGen CA396382618, ClinVar RCV003339161, REVEL 0.37, CADD 25.00, Uncertain significance, Cardiovascular phenotype
- E41G (p.Glu41Gly), Ensembl rs909993407, REVEL 0.28, CADD 22.80, Uncertain significance, Cardiovascular phenotype
- S43N (p.Ser43Asn), 1000Genomes rs143128684, ExAC rs143128684, gnomAD rs143128684, REVEL 0.23, CADD 16.40
- S43R (p.Ser43Arg), TOPMed rs1489598307, gnomAD rs1489598307, REVEL 0.26, CADD 22.40
- S43T (p.Ser43Thr), 1000Genomes rs143128684, ExAC rs143128684, gnomAD rs143128684, REVEL 0.21, CADD 17.30
- N44D (p.Asn44Asp), Ensembl rs2058312669, REVEL 0.59, CADD 25.40
- H45Y (p.His45Tyr), Ensembl rs2058312607
- T46I (p.Thr46Ile), gnomAD rs1433630587, REVEL 0.53, CADD 24.50
- T46S (p.Thr46Ser), rs761720102, ClinGen CA8121172, ClinVar RCV002383664, ExAC rs761720102, REVEL 0.53, CADD 23.70, Uncertain significance, Cardiovascular phenotype
- T46A (p.Thr46Ala), rs761272947, gnomAD 16-67940063-T-C, CADD 1.17
- T46P (p.Thr46Pro), rs761272947, gnomAD 16-67940063-T-G, CADD 1.10
- R47Q (p.Arg47Gln), rs774333955, NCI-TCGA Cosmic COSV5045, ExAC rs774333955, gnomAD rs774333955, REVEL 0.36, CADD 22.60, Uncertain significance, not provided
- R47W (p.Arg47Trp), gnomAD rs1172331185, REVEL 0.63, CADD 24.40, Uncertain significance, Cardiovascular phenotype
- P48L (p.Pro48Leu), gnomAD rs1378606015, REVEL 0.96, CADD 27.10, Uncertain significance, Cardiovascular phenotype
- V49I (p.Val49Ile), rs1417533036, ClinGen CA396382465, NCI-TCGA Cosmic COSV5045, ClinVar RCV004522814, REVEL 0.35, CADD 17.80, Uncertain significance, Fish-eye disease; Norum disease; Cardiovascular phenotype
- I50V (p.Ile50Val), NCI-TCGA TCGA novel, REVEL 0.22, CADD 15.40, Variant assessed as somatic; moderate impact.
- L51P (p.Leu51Pro), TOPMed rs2058312297
- V52M (p.Val52Met), rs763018899, NCI-TCGA Cosmic COSV9986, ExAC rs763018899, gnomAD rs763018899, REVEL 0.84, CADD 33.00, Uncertain significance, not provided
- P53L (p.Pro53Leu), ExAC rs751256574, gnomAD rs751256574, CADD 2.15
- P53S (p.Pro53Ser), Ensembl rs2058302699, CADD 2.25
- P53A (p.Pro53Ala), rs761312598, gnomAD 16-67940072-G-C, CADD 6.87
- G54S (p.Gly54Ser), rs1461145750, ClinGen CA396382229, ClinVar RCV003405840, ClinVar RCV003553898, REVEL 0.89, CADD 28.30, Likely pathogenic, not provided; LCAT-related disorder
- C55R (p.Cys55Arg), rs2058283997, gnomAD 16-67940057-A-G, CADD 7.19
- L56P (p.Leu56Pro), ExAC rs762600330, TOPMed rs762600330, gnomAD rs762600330, REVEL 0.78, CADD 28.40, Conflicting interpretations, not provided; Decreased circulating HDL-C concentration; Fish-eye disease
- G57R (p.Gly57Arg), rs2058302561, ClinGen CA396382170, ClinVar RCV003559928, UniProt VAR 004254, REVEL 0.92, AlphaMissense 0.97, Uncertain significance, not provided
- G57V (p.Gly57Val), Ensembl rs2151321324
- Q59R (p.Gln59Arg), Ensembl rs2151321318
- L60P (p.Leu60Pro), TOPMed rs1474727071, gnomAD rs1474727071, CADD 10.60
- E61* (p.Glu61Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A62D (p.Ala62Asp), TOPMed rs1193505445
- A62T (p.Ala62Thr), rs1012071419, gnomAD 16-67940039-C-T, CADD 7.57
- A62S (p.Ala62Ser), rs1044889786, gnomAD 16-67940045-C-A, CADD 9.07
- A62V (p.Ala62Val), gnomAD 16-67940047-G-A, CADD 5.44
- D65Y (p.Asp65Tyr), ExAC rs760768147
- P67A (p.Pro67Ala), rs2544407578, ClinGen CA396381998, ClinVar RCV004522815, Uncertain significance, Cardiovascular phenotype
- P67T (p.Pro67Thr), gnomAD 16-67939997-G-T, CADD 3.64
- P67L (p.Pro67Leu), gnomAD 16-67940002-G-A, CADD 9.01
- P67S (p.Pro67Ser), rs745833816, gnomAD 16-67940042-G-A, CADD 9.46
- D68G (p.Asp68Gly), rs2058302402, ClinGen CA396381983, ClinVar RCV003342002, TOPMed rs2058302402, AlphaMissense 0.11, MetaLR 0.77, Uncertain significance, Cardiovascular phenotype
- D68H (p.Asp68His), 1000Genomes rs538047729, ExAC rs538047729, TOPMed rs538047729, gnomAD rs538047729, REVEL 0.24, CADD 18.00
- V69L (p.Val69Leu), ExAC rs772109225, gnomAD rs772109225, REVEL 0.34, CADD 20.60
- V70E (p.Val70Glu), rs748427834, UniProt VAR 039023, ExAC rs748427834, TOPMed rs748427834, REVEL 0.90, AlphaMissense 0.42, Uncertain significance, Norum disease; Fish-eye disease
- M73I (p.Met73Ile), rs769067928, ExAC rs769067928, TOPMed rs769067928, gnomAD rs769067928, AlphaMissense 0.46, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- C74W (p.Cys74Trp), gnomAD rs1242606598, REVEL 0.84, CADD 27.40
- C74* (p.Cys74Ter), gnomAD 16-67939980-G-T, REVEL 0.23, CADD 18.20
- Y75C (p.Tyr75Cys), ExAC rs749574144, TOPMed rs749574144, gnomAD rs749574144, REVEL 0.61, CADD 24.30
- R76C (p.Arg76Cys), TOPMed rs1055719644, gnomAD rs1055719644, REVEL 0.63, CADD 27.30
- R76H (p.Arg76His), rs756625482, ClinGen CA8121141, ClinVar RCV002446065, ClinVar RCV005019199, REVEL 0.57, CADD 25.50, Uncertain significance, Fish-eye disease; Norum disease; Cardiovascular phenotype
- R76L (p.Arg76Leu), ExAC rs756625482, TOPMed rs756625482, gnomAD rs756625482, REVEL 0.60, CADD 23.70, Uncertain significance, Cardiovascular phenotype
- R76W (p.Arg76Trp), rs202010908, gnomAD 16-67940036-G-A, CADD 0.12
- K77Q (p.Lys77Gln), ExAC rs746342275, gnomAD rs746342275, REVEL 0.68, CADD 27.10
- T78I (p.Thr78Ile), ExAC rs780912694, REVEL 0.71, CADD 25.60
- E79D (p.Glu79Asp), ExAC rs756818645, TOPMed rs756818645, gnomAD rs756818645, REVEL 0.21, CADD 13.90, Likely benign
- F82L (p.Phe82Leu), ExAC rs751274627, gnomAD rs751274627
- F82V (p.Phe82Val), Ensembl rs2151321271
- T83S (p.Thr83Ser), ExAC rs763589763, gnomAD rs763589763, REVEL 0.51, CADD 23.70
- W85* (p.Trp85Ter), TOPMed rs1328187167, gnomAD rs1328187167, CADD 35.00, Likely pathogenic
- W85R (p.Trp85Arg), ExAC rs758245988, TOPMed rs758245988, gnomAD rs758245988, REVEL 0.82, CADD 24.30, Uncertain significance, Cardiovascular phenotype
- D87G (p.Asp87Gly), TOPMed rs1343446831, gnomAD rs1343446831, REVEL 0.72, CADD 29.60
- D87Y (p.Asp87Tyr), rs2544407421, ClinGen CA396381575, ClinVar RCV002426208, REVEL 0.79, CADD 25.60, Uncertain significance, Cardiovascular phenotype
- L88F (p.Leu88Phe), ExAC rs752387253, gnomAD rs752387253, REVEL 0.40, CADD 22.60
- L88R (p.Leu88Arg), TOPMed rs2058301907
- M90L (p.Met90Leu), ExAC rs765059218, gnomAD rs765059218, REVEL 0.27, CADD 16.20, Uncertain significance, Norum disease; Fish-eye disease
- M90R (p.Met90Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M90V (p.Met90Val), ExAC rs765059218, gnomAD rs765059218, REVEL 0.52, CADD 22.30, Uncertain significance
- F91L (p.Phe91Leu), gnomAD rs2058301852, REVEL 0.50, CADD 20.10
- L92I (p.Leu92Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P93S (p.Pro93Ser), rs1440905440, gnomAD 16-67939928-G-A, CADD 8.75
- P93A (p.Pro93Ala), rs2058283076, gnomAD 16-67939940-G-C, CADD 2.29
- P93T (p.Pro93Thr), rs2058283158, gnomAD 16-67939949-G-T, CADD 4.31
- L94F (p.Leu94Phe), ExAC rs776536104, gnomAD rs776536104, REVEL 0.31, CADD 17.70
- G95V (p.Gly95Val), Ensembl rs866636551
- V96L (p.Val96Leu), TOPMed rs2058301750, REVEL 0.60, CADD 23.30
- C98R (p.Cys98Arg), rs1394425052, gnomAD 16-67939967-A-G, CADD 9.19
- W99R (p.Trp99Arg), Ensembl rs2058301707, REVEL 0.93, CADD 29.00
- W99S (p.Trp99Ser), UniProt VAR 066862, Pathogenic, in FED
- I100V (p.Ile100Val), TOPMed rs2058301679
- I100L (p.Ile100Leu), gnomAD 16-67939943-T-G, CADD 0.90
- D101N (p.Asp101Asn), rs538148718, ExAC rs538148718, TOPMed rs538148718, gnomAD rs538148718, REVEL 0.81, CADD 27.50, Uncertain significance, not provided
- N102S (p.Asn102Ser), TOPMed rs1347227877, gnomAD rs1347227877, REVEL 0.79, CADD 25.00
- N102T (p.Asn102Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N102Y (p.Asn102Tyr), ExAC rs774662407, TOPMed rs774662407, gnomAD rs774662407, REVEL 0.93, CADD 26.40
- R104K (p.Arg104Lys), TOPMed rs1282287185, gnomAD rs1282287185, REVEL 0.67, CADD 35.00
- V106A (p.Val106Ala), Ensembl rs2058300665
- V106I (p.Val106Ile), NCI-TCGA TCGA novel, REVEL 0.31, CADD 7.35, Variant assessed as somatic; moderate impact.
- Y107* (p.Tyr107Ter), rs121908055, ClinGen CA116426, ClinVar RCV000003856, ClinVar RCV002496248, CADD 36.00, Pathogenic
- N108S (p.Asn108Ser), ExAC rs761902457, gnomAD rs761902457, REVEL 0.66, CADD 25.30
- R109Q (p.Arg109Gln), ExAC rs764199690, TOPMed rs764199690, gnomAD rs764199690, REVEL 0.45, CADD 22.20
- R109W (p.Arg109Trp), rs751636804, ClinGen CA8121110, ClinVar RCV002710099, ExAC rs751636804, REVEL 0.55, CADD 28.10, Uncertain significance, not provided
- S111P (p.Ser111Pro), Ensembl rs2058300556, REVEL 0.67, CADD 25.10
- V114L (p.Val114Leu), 1000Genomes rs35673026, ESP rs35673026, ExAC rs35673026, TOPMed rs35673026, REVEL 0.30, CADD 11.00, Uncertain significance, Norum disease; Fish-eye disease
- V114M (p.Val114Met), rs35673026, ClinGen CA8121104, ClinVar RCV001117249, ClinVar RCV001469271, REVEL 0.69, CADD 11.90, Benign/Likely benign, not provided; Cardiovascular phenotype; Norum disease
- S115P (p.Ser115Pro), rs1412883954, UniProt VAR 039025, gnomAD rs1412883954, AlphaMissense 0.72, MetaLR 0.88
- N116S (p.Asn116Ser), rs771517943, ExAC rs771517943, TOPMed rs771517943, gnomAD rs771517943, REVEL 0.55, CADD 23.70, Uncertain significance, Cardiovascular phenotype
- A117T (p.Ala117Thr), rs28940886, ClinVar RCV000003852, UniProt VAR 004255, ExAC rs28940886, REVEL 0.58, AlphaMissense 0.79, no classification for the single variant, in LCATD
- A117P (p.Ala117Pro), gnomAD 16-67939916-C-G, CADD 1.37
- P118R (p.Pro118Arg), Ensembl rs2151321148
- P118T (p.Pro118Thr), Ensembl rs2058300402
- V120A (p.Val120Ala), rs766209201, ClinGen CA283163127, ClinVar RCV004522816, Ensembl rs766209201, REVEL 0.86, CADD 25.70, Uncertain significance, Cardiovascular phenotype
- V120I (p.Val120Ile), ExAC rs771607670, gnomAD rs771607670, REVEL 0.60, CADD 24.60
- Q121* (p.Gln121Ter), Ensembl rs1567409195
- Q121H (p.Gln121His), rs1472608950, ClinGen CA396380947, ClinVar RCV004412405, TOPMed rs1472608950, REVEL 0.34, AlphaMissense 0.92, Uncertain significance, Cardiovascular phenotype
- I122V (p.Ile122Val), rs2151321143, ClinGen CA396380938, ClinVar RCV002452472, Ensembl rs2151321143, REVEL 0.24, CADD 19.10, Uncertain significance, Cardiovascular phenotype
- R123C (p.Arg123Cys), rs140068549, ClinGen CA8121100, ClinVar RCV000779196, ClinVar RCV002501012, REVEL 0.93, CADD 28.30, Likely pathogenic, Fish-eye disease; Norum disease; LCAT deficiency
- R123H (p.Arg123His), rs199717050, ClinGen CA8121099, ClinVar RCV001794818, ExAC rs199717050, REVEL 0.68, CADD 24.90, Conflicting interpretations, not provided
- R123P (p.Arg123Pro), ExAC rs199717050, TOPMed rs199717050, gnomAD rs199717050, REVEL 0.82, CADD 26.00, Uncertain significance, Norum disease; Fish-eye disease
- V124I (p.Val124Ile), rs753579128, ClinGen CA8121097, ClinVar RCV002349000, ExAC rs753579128, REVEL 0.51, CADD 23.00, Uncertain significance, Cardiovascular phenotype
- G126S (p.Gly126Ser), gnomAD rs1211248313, REVEL 0.84, CADD 26.60
- G126V (p.Gly126Val), Ensembl rs1598204313
- F127V (p.Phe127Val), gnomAD rs1446799939, REVEL 0.93, AlphaMissense 0.99
- G128A (p.Gly128Ala), Ensembl rs2058300148
- G128S (p.Gly128Ser), rs199560940, ClinGen CA8121096, ClinVar RCV001117248, ClinVar RCV001856538, REVEL 0.91, CADD 27.20, Uncertain significance, not provided; Cardiovascular phenotype; Norum disease
- T130I (p.Thr130Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y131F (p.Tyr131Phe), gnomAD rs1329882443, REVEL 0.31, CADD 19.10
- S132Y (p.Ser132Tyr), NCI-TCGA Cosmic COSV5045, Variant assessed as somatic; moderate impact.
- Y135* (p.Tyr135Ter), gnomAD rs1231577814, CADD 35.00
- L136V (p.Leu136Val), 1000Genomes rs151178077, ESP rs151178077, ExAC rs151178077, TOPMed rs151178077, REVEL 0.42, CADD 17.10, Likely benign
- D137N (p.Asp137Asn), rs2544406891, ClinGen CA396380706, ClinVar RCV002323306, Uncertain significance, Cardiovascular phenotype
- D137V (p.Asp137Val), Ensembl rs2058300015
- S138G (p.Ser138Gly), NCI-TCGA Cosmic COSV5045, TOPMed rs2058299997, Variant assessed as somatic; moderate impact.
- Y144D (p.Tyr144Asp), Ensembl rs2058299120
- L145P (p.Leu145Pro), rs2544406628, ClinGen CA396380434, ClinVar RCV004522817, Uncertain significance, Cardiovascular phenotype
- T147I (p.Thr147Ile), rs121908050, ClinGen CA116418, ClinVar RCV000003845, ClinVar RCV002504739, REVEL 0.83, CADD 24.30, Pathogenic, Norum disease; Fish-eye disease; not provided
- N151K (p.Asn151Lys), ExAC rs754109587, gnomAD rs754109587, REVEL 0.49, CADD 12.70
- V153A (p.Val153Ala), Ensembl rs1186825177
- N155D (p.Asn155Asp), rs121908057, ClinGen CA116431, ClinVar RCV000003858, Ensembl rs121908057, REVEL 0.44, AlphaMissense 0.55, Pathogenic, Fish-eye disease
- N155S (p.Asn155Ser), Ensembl rs1013678741, REVEL 0.44, CADD 22.00
- V158E (p.Val158Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V158M (p.Val158Met), rs761032474, ClinGen CA8121070, ClinVar RCV002994864, ClinVar RCV005019551, REVEL 0.40, CADD 24.00, Uncertain significance, Fish-eye disease; Norum disease; not provided
- R159Q (p.Arg159Gln), rs768017317, UniProt VAR 039027, ExAC rs768017317, TOPMed rs768017317, REVEL 0.90, CADD 25.60, Pathogenic, in FED
- R159W (p.Arg159Trp), rs28940887, ClinGen CA116423, ClinVar RCV000003853, ClinVar RCV002512727, REVEL 0.92, CADD 27.60, Likely pathogenic, not provided
- D160Y (p.Asp160Tyr), ExAC rs762202276, gnomAD rs762202276
- E161K (p.Glu161Lys), rs768148804, ClinGen CA8121066, ClinVar RCV001117244, ClinVar RCV002491366, REVEL 0.60, CADD 22.50, Uncertain significance, Norum disease; Fish-eye disease; LCAT deficiency
- T162A (p.Thr162Ala), gnomAD rs2058298709, REVEL 0.61, CADD 22.90
- V163L (p.Val163Leu), ExAC rs748994180, TOPMed rs748994180, gnomAD rs748994180, REVEL 0.64, CADD 22.10
- V163M (p.Val163Met), ExAC rs748994180, TOPMed rs748994180, gnomAD rs748994180, REVEL 0.71, CADD 23.70
- R164C (p.Arg164Cys), rs1380009545, NCI-TCGA Cosmic COSV5045, UniProt VAR 039028, TOPMed rs1380009545, REVEL 0.93, CADD 24.80, Pathogenic, in LCATD
- R164H (p.Arg164His), rs769485083, ClinGen CA8121062, ClinVar RCV001975068, UniProt VAR 004258, REVEL 0.90, CADD 24.50, Pathogenic/Likely pathogenic, not provided
Public LCAT analysis runs
- LCAT analysis run — LCAT (667 variants) — completed 2026-08-21